GB201517565D0 - Treatment of genetic diseases - Google Patents
Treatment of genetic diseasesInfo
- Publication number
- GB201517565D0 GB201517565D0 GBGB1517565.6A GB201517565A GB201517565D0 GB 201517565 D0 GB201517565 D0 GB 201517565D0 GB 201517565 A GB201517565 A GB 201517565A GB 201517565 D0 GB201517565 D0 GB 201517565D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- treatment
- genetic diseases
- genetic
- diseases
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (11)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1517565.6A GB201517565D0 (en) | 2015-10-05 | 2015-10-05 | Treatment of genetic diseases |
KR1020187011879A KR20180053753A (en) | 2015-10-05 | 2016-10-05 | Use of single-stranded antisense oligonucleotides for the prevention or treatment of genetic diseases associated with trinucleotide repeat extension |
US15/765,864 US10760076B2 (en) | 2015-10-05 | 2016-10-05 | Use of single-stranded antisense oligonucleotide in prevention or treatment of genetic diseases involving a trinucleotide repeat expansion |
EP16779049.2A EP3359667A1 (en) | 2015-10-05 | 2016-10-05 | Use of single-stranded antisense oligonucleotide in prevention or treatment of genetic diseases involving a trinucleotide repeat expansion |
AU2016335032A AU2016335032B2 (en) | 2015-10-05 | 2016-10-05 | Use of single-stranded antisense oligonucleotide in prevention or treatment of genetic diseases involving a trinucleotide repeat expansion |
JP2018536344A JP7089763B2 (en) | 2015-10-05 | 2016-10-05 | Use of single-stranded antisense oligonucleotides in the prevention or treatment of genetic disorders involving trinucleotide repeat elongation |
CN201680058611.9A CN108291225B (en) | 2015-10-05 | 2016-10-05 | Use of single-stranded antisense oligonucleotides for preventing or treating genetic diseases involving repeated amplification of trinucleotide |
CA3000061A CA3000061C (en) | 2015-10-05 | 2016-10-05 | Use of single-stranded antisense oligonucleotide in prevention or treatment of genetic diseases involving a trinucleotide repeat expansion |
PCT/EP2016/073817 WO2017060317A1 (en) | 2015-10-05 | 2016-10-05 | Use of single-stranded antisense oligonucleotide in prevention or treatment of genetic diseases involving a trinucleotide repeat expansion |
US16/983,129 US20200362348A1 (en) | 2015-10-05 | 2020-08-03 | Use of single-stranded antisense oligonucleotide in prevention or treatment of genetic diseases involving a trinucleotide repeat expansion |
JP2022016668A JP2022070913A (en) | 2015-10-05 | 2022-02-04 | Use of single-stranded antisense oligonucleotides in prevention or treatment of genetic diseases involving trinucleotide repeat expansion |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1517565.6A GB201517565D0 (en) | 2015-10-05 | 2015-10-05 | Treatment of genetic diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
GB201517565D0 true GB201517565D0 (en) | 2015-11-18 |
Family
ID=54606100
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB1517565.6A Ceased GB201517565D0 (en) | 2015-10-05 | 2015-10-05 | Treatment of genetic diseases |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB201517565D0 (en) |
-
2015
- 2015-10-05 GB GBGB1517565.6A patent/GB201517565D0/en not_active Ceased
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1246179A1 (en) | Methods of treating retinal diseases | |
IL290980A (en) | Rna for treatment of autoimmune diseases | |
EP3273955A4 (en) | Treatment of respiratory diseases | |
HK1258994A1 (en) | Methods for treatment of diseases | |
ZA201903003B (en) | Treatment of neurological diseases | |
GB201516905D0 (en) | Treatment of Neurodegenerative diseases | |
GB201412578D0 (en) | Treatment of neurological diseases | |
HK1246679A1 (en) | Treatment of filarial diseases | |
HK1243937A1 (en) | Methods of treating diseases | |
PL3302499T3 (en) | Treatment of mitochondrial diseases | |
PL3182980T3 (en) | Treatment of glycosylation deficiency diseases | |
IL259381B (en) | Mirabegron for the treatment of retinal diseases | |
PL3302463T3 (en) | Use of 3-deoxyanthocyanidins for treating ocular diseases | |
GB201517565D0 (en) | Treatment of genetic diseases | |
GB201604253D0 (en) | Treatment of genetic diseases | |
GB201621398D0 (en) | Treatment of emt-associated disease | |
GB201514909D0 (en) | Treatment of autoimmune diseases | |
GB201504413D0 (en) | Treatment of disease | |
GB201414023D0 (en) | Treatment of autoimmune diseases | |
AU2015901032A0 (en) | Treatment of respiratory diseases | |
GB201501800D0 (en) | Treatment of medical conditions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |